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Key messages
Policy issue
• International health system performance comparisons have the potential
to provide a rich source of evidence as well as policy influence. 
• Country comparisons that are not conducted with properly validated
measures and unbiased policy interpretations may prompt adverse 
policy impacts and so caution is required in the selection of indicators, 
the methodologies used, and the interpretations made. 
Lessons from international comparisons
• International health system comparisons provided by multilateral
institutions such as the WHO or the OECD have generated much interest
since the publication of the 2000 World Health Report, which highlighted
the potential for cross-country learning from the scrutiny of comparable
data, and also the challenges that must be overcome: 
• Definitions of performance indicators should be clear and consistent,
and fit into a clear conceptual framework. 
• The metrics used in international comparison should enjoy
widespread acceptance, and are defined in unambiguous terms 
that are consistent with most countries’ data collection systems. 
• In order to draw meaningful comparisons and understand the drivers
of differences in measures between systems it is usually necessary 
to adjust for variations in the demographic, social, cultural and
economic circumstances of nations.
• “Single number” measures of whole health system performance,
while offering a more rounded view of performance, have limited
scope for policy action, and may distract policy-makers from seeking
out and remedying the parts of their system that require attention.
• Lessons from benchmarking activities in other sectors suggest that – 
when applied to health systems – benchmarking will be most effective 
if it focuses on practice as well as performance; is grounded in the 
broader change process; is well structured and planned in order to 
engage stakeholders; and carefully considers how performance is 
linked to resource allocation. 
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Lessons from recent experience in health system comparison
• In defining the boundaries of the health system it is important to be aware
of the benefits of choosing both narrow and wide boundaries. Narrow
boundaries are better suited to holding stakeholders accountable, while
broader boundaries are better for a more holistic understanding of the
determinants of valued outcomes.
• Performance measurement evaluates the extent to which a health system
meets its key objectives. However progress in the development of data
collection techniques in the different dimensions of health performance 
is variable.
• While efforts should be undertaken to improve data collection efforts,
policy-makers should also make themselves familiar with limitations in
existing indicators in order to be able to interpret them appropriately. 
Comparing key domains of performance
• Population health measures often take a broad perspective, which captures
the effect of many determinants of health beyond the delivery of health
care. This broad perspective can be attractive from a political point of view
because it draws attention to the importance of many sectors in determining
health outcomes. However it also creates major methodological challenges
in seeking to attribute changes in health to any particular actions. A
narrower perspective, such as the concept of avoidable mortality, focuses
on measures that can more easily be attributed to health care, and which
are therefore more amenable to immediate health policy.
• All population health indicators suffer from a number of methodological
problems, which need to be addressed in order to make international
comparisons more meaningful. Some of the main issues involve availability
and coding of data, particularly of data on cause of death where there 
are problems of comparability among countries and over time.
• Direct indicators of the contribution of health services to health status 
are available in the form of health service quality measures, such as
standardized hospital mortality rates and numerous disease-specific 
health outcome measures, such as mortality rates, adverse events and
complications. Far less prevalent are broader outcome measures in areas
such as disabilities and discomfort.
• While existing health service measures offer some indicators of the
performance of individual organizations, international comparison 
is complicated by different organizational settings and reporting
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conventions, even after suitable adjustment for case-mix and other
contextual circumstances.
• Although comparative indicators on inequality of health and equity in
access to health care are available at both European and non-European
level, equity indicators derived from existing projects and datasets may 
be misleading for policy-makers due to limitations in the availability and
comparability of data. 
• The many aspects of financial protection have yielded some important
indicators, such as the incidence of catastrophic expenditure. However it
has proved difficult to develop a single indicator capturing the full extent 
to which people are financially protected from health shocks. Currently,
measures of the incidence and magnitude of households’ direct payments
for health care form the basis of metrics for financial protection
assessment and system comparisons.
• There is still lack of clarity as to what dimensions should be included in 
the domain of responsiveness, which embraces concepts such as respect,
confidentiality and prompt attention. This uncertainty leads to the
measurement of different areas using different tools with different
weights, domains and indicators that are difficult to summarize and
compare. 
• Efficiency indicators serve as a summary measure of the extent to which 
the inputs to the health system, in the form of expenditures and other
resources, are used wisely to secure the goals of the health system. Almost
all efficiency indicators are constructed as a ratio of inputs to outputs,
offering an indication of the extent to which resources have been wasted
along some or all of the production pathway. 
• In measuring efficiency, a fundamental challenge is the assignment of
inputs and associated costs to specific health system activities, often 
relying on arbitrary accounting rules or other questionable assignments. 
In principle, the inputs used should be directly and fully aligned with the
output under scrutiny. 
Future directions
• The key requirements for creating comparable indicators that address the
needs of policy-makers are: appropriate methods of summarizing complex
information; a narrative that picks out the key issues and uncertainties; a
diagnosis of why the reported variations are arising; and an assessment of
the implications for policy action.
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1 Policy issue: why use international comparisons?
Individual nations are increasingly seeking to introduce more systematic ways 
of assessing the performance of their health systems, and of benchmarking
performance against other countries. Policy-makers recognize that without
measurement and comparison, it is difficult to identify good and bad delivery
practice or good or bad practitioners (“what or who works”), to design 
health system reforms, to protect patients and payers, or to make the 
case for investing in health care. Measurement is also central to promoting
accountability to citizens, patients and payers for health system actions and
outcomes. This focus on assessment coincides with the enormous increase 
in the capacity for measurement and analysis of the last decade, driven in 
no small part by massive changes in information technology and associated
advances in measurement methodology.
However, notwithstanding major progress by organizations such as the
European Commission, the OECD, the Commonwealth Fund, the WHO and
individual countries, performance comparison efforts are in their early stages,
and there are many challenges involved in the design and implementation of
comparison schemes.
The state of current developments in performance measurement is
comprehensively surveyed in the book that followed the Tallinn conference:
Performance measurement for health system improvement (Smith et al., 2009).
The book identified the important sources of international comparison noted
above, but also highlighted the limits in many performance assessment
initiatives both in terms of their scope and their policy usefulness. It exposed
the difficulties of interpreting sources of performance information from 
a health system policy perspective. It also draws attention to the danger 
that the existing focus on partial aspects of performance may lead to serious
policy misconceptions if not accompanied by a careful commentary on the
implications of variations for health system improvement and reform. Care 
and review are all the more important in light of the growing appetite for 
cross-country performance comparisons and benchmarking by Member States,
citizens and the media, and the pressures that can arise from it. 
In sum, properly conducted country comparisons of performance may constitute
a rich source of evidence and powerful influence on policy. However, caution is
required as initiatives that rely on poorly validated measures and biased policy
interpretations may lead to ineffective or even adverse policy choices. 
There is therefore a need to harness the potential of comparative health
systems performance assessment (HSPA), building on credible initiatives and
strengthening both the methodologies and the policy analysis. This includes
highlighting not only the policy “uses” but also the policy “abuses” of
Health system performance comparison
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comparisons. In other words, as well as drawing out the information content
and potential of performance measures, analysts should indicate what cannot
be inferred from the analysis, showing the limitations of current measures and
suggesting fruitful future improvements.
This policy brief seeks to summarize the current “state of the art” of health
system comparison, identifying data and methodological issues and exploring
the current interface between evidence and practice. It also draws out the
priorities for future work on performance comparison, in the development of
measurement instruments, analytic methodology, and assessment of evidence
on performance. It will conclude by presenting key lessons and future priorities
policy-makers should take into account.
2 Lessons from international comparisons to date
a. Lessons from international comparisons in health
International health system comparisons provided by multilateral institutions
such as the WHO or the OECD have generated much interest since the
publication of the 2000 World health report (WHO, 2000). While desultory
performance measurement efforts occurred long before the report, dating 
back over a century, this publication highlighted the potential for cross-country
learning from the scrutiny of comparable data. Through careful examination of
the lessons from the 2000 World health report and other large-scale international
health system comparisons that have been developed since, some conclusions
can be drawn regarding lessons that this practical experience can offer.
There has been a fierce debate over the virtues of producing a “single number”
measure of whole health system performance. Such composite measures offer
a more rounded view of performance than a series of fragmentary metrics that
offer insights into the performance of parts of the health system. However, they
may disguise weaknesses in specific parts of health systems, and are difficult to
interpret. Experience suggests that at the current stage of measurement and
methodological development the usefulness of “whole-system” performance
comparison is open to question, especially when used for global rankings of
health systems. Such endeavours are readily open to challenge and may distract
policy-makers from identifying and remedying the parts of their system that
require attention.
Most performance measures are contestable and exhibit shortcomings of 
some sort. This calls for careful commentaries on existing data and better
understanding of the reasons for variations between health systems. From 
an international comparative perspective, the crucial requirement is that such
metrics are relevant to health system goals, enjoy widespread acceptance, and
Policy summary
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are defined in unambiguous terms that are consistent with most countries’ 
data collection systems. Where there may be discrepancies in data collection 
or reporting this should be presented clearly alongside the metric. 
Progress has been made in certain areas, such as some aspects of health 
system quality comparison and accounting conventions. However, there are
many domains of health system performance where there is no consensus 
on how metrics are to be conceptualized or measured, such as responsiveness,
equity and efficiency. Moreover, in order to draw meaningful comparisons 
and understand the drivers of differences in measures between systems it is
usually necessary to adjust for variations in the demographic, social, cultural
and economic circumstances of nations. Many analyses make rudimentary
adjustments for variation in demographic profiles, but more advanced progress
in this area has been very limited, partly because a lack of information available
to adjust for such circumstances. There is therefore clearly a major international
agenda to be addressed to agree a conceptual framework for collecting
comparative information, the domains that require measures, and the
specification of those measures.
For assessment purposes, moreover, particular care should be taken when
examining just a single snapshot (cross-section) of comparative performance.
The use of time series can offer more secure inferences, but places greater
demands on data availability. Outcomes (such as mortality) are often the
product of the inputs of previous years, and will not necessarily be a reflection
of the performance of the current health system. Conversely, current inputs
may contribute in part to future attainment. A naive comparison of current
levels of attainment might ignore the trajectory of the health system, for
example attributing good current performance to current efforts, rather than
(say) preventative programmes in the past. It is therefore highly desirable that
any comparison of such outcomes takes into account these time lags – the
comparison should be dynamic.
b. Lessons from other sectors
When considering how international comparisons can be most beneficial in health
systems it is important to look beyond what has been done in health and learn
from the experience of benchmarking efforts in other sectors. Indeed there is 
a widespread interest in and take up of benchmarking that appears to be an
international phenomenon. Different forms of benchmarking have different
aims and different lessons. A key distinction can be made between performance
benchmarking and practice benchmarking. Performance benchmarking
concentrates on establishing performance standards, while practice benchmarking
is concerned with establishing the reasons why organizations achieve the level
of performance that they do. Evidence suggests that performance benchmarking
Health system performance comparison
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is more prevalent than practice benchmarking, although it can be argued that
practice benchmarking is more beneficial in the long run. 
There are practical challenges to benchmarking. Deciding what and how 
to benchmark, which organizations to compare with and how to ensure
comparability, what data to use and whether the data are robust, all affect 
its value. Particularly in practice benchmarking, one does not always need to
seek organizational comparability. Indeed, when focusing on how to improve
processes within organizations it is often helpful to compare organizations from
very different sectors. One of the original proponents of benchmarking, Xerox,
compared itself with LL Bean, a mail order company because Xerox wanted to
improve its warehousing and distribution processes and LL Bean was recognized
as having excellent warehousing and distribution processes.
Benchmarking is at its most impactful when integrated with a broader
programme of change. This raises questions of who should benchmark (self-
assessment versus external agencies) and to whom the subsequent information
should be released. If benchmarking is carried out by external agencies and the
data subsequently made public (as is often the case in the health sector) then
there is a strong incentive for those being benchmarked to become defensive
and seek to paint their organization in the best possible light. In extreme cases,
this can result in perverse and dysfunctional behaviour, where people take
actions that make the benchmark numbers look better, even though these
actions do not really improve organizational performance.
The most common reasons for benchmarking are to improve efficiency 
and reduce cost, although the benefits of benchmarking are not limited to
efficiency gains. Indeed benchmarking can deliver new insights that improve
the quality of service delivered. Given the current financial situation in many
countries, however, it is likely that we will see a strong focus on benchmarking
for efficiency gains – identifying ways in which we can do more for less 
(or perhaps less for less).
In addition to the direct benefits of benchmarking, there can be indirect
benefits. These apply especially in terms of cultural change and opening up 
the organization to new ideas. Encouraging staff to visit and understand the
way other organizations work can be very powerful in opening staff’s eyes.
Indeed it is claimed that the Toyota Production System was inspired partly by
visits from Taiichi Ohno and colleagues to American supermarkets, where they
observed a much smoother flow of work than one would traditionally find in
manufacturing plants.
Clearly there are challenges of benchmarking, as well as benefits. Indeed, 
some organizations claim to have achieved no benefit from their benchmarking
activities, while others claim to have achieved significant benefit. An important
Policy summary
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distinction between these two groups – those that claim to benefit from
benchmarking and those that do not – is the extent to which benchmarking
focuses on strategic priorities, involves clear and careful planning, and any
practices identified are not simply adopted wholesale, but instead adapted
appropriately for the adopting organization.
Questions remain about whether benchmarks should be linked to incentives
and/or budgets. Clearly, for reasons of accountability and transparency, this
might be useful. Additionally, in the not-for-profit sector there is some attempt
to use benchmarks as a replacement for the market mechanism. Given there
are no formal competitors for many public services, benchmarks provide a form
of competitive comparison. Box 1 illustrates some of the lessons that can be
applied from other areas to benchmarking in health systems. 
c. Frameworks for comparison
International comparison of health system performance can exert a major
influence on national policy-makers. The response to the World health report
2000 was an indication of the potential power of such comparison, but also
highlighted the severe methodological difficulties that arise when seeking to
make it operational. The starting point of most international comparisons 
is the creation of a conceptual framework on which to base the collection of
information and to use as a heuristic for the understanding of the health system. 
In the past decade much energy has been put into the creation of a variety of
conceptual frameworks at the international level (Aday et al., 2004; Arah et al.,
Box 1. Lessons of benchmarking for health systems
From what is known of benchmarking in other sectors, five implications can be
extended to benchmarking efforts in the health system: 
1. Health benchmarks should focus on practice as well as performance.
2. Health benchmarks should not be used simply to evaluate and compare
performance.
3. Benchmarks need to be grounded in a broader change process. 
4. The benchmarking process itself needs to be well structured, well planned and
designed to engage people in making change in their organizations.
5. The designers of health benchmarking systems need to consider very carefully
the link between resource allocation and benchmark performance if they are
to avoid dysfunctional behaviour.
Source: Adapted from Neely, forthcoming.
2006; Atun & Mendabde, 2008; Commonwealth Fund, 2006; Hurst & Jee-
Hughes, 2001; IHP,2008; Jee & Or, 1999; Kelley & Hurst, 2006; Klassen et al.,
2009; Murray & Frenk, 2000; Roberts et al., 2008; Sicotte et al., 1998). 
While these frameworks have varied purposes they all aim to provide a better
understanding of what a health system is, its goals, and the underlying structure
and factors that drive its performance. Indeed careful examination of the
available international frameworks suggests that over time there is a degree 
of convergence, both in the framework architecture and goals but also in the
problem areas they encounter. This suggests that the gains from a creating a new
framework have progressively decreased in proportion to the efforts required to
undertake such a task. The priority now is to clarify areas where there are long-
standing differences in matters of understanding, focus and principle. 
One of the main areas of debate that needs to be addressed is determining
where the boundaries of the health system lie. There can be no right answer to
this question, as there are sound reasons for promoting the use of both wider
and narrower boundaries. Narrow boundaries are better suited to holding
stakeholders accountable, while broader boundaries are better for a more
holistic understanding of determinants (Figure 1). Moreover, boundaries that
correspond to the goals of the entity undertaking HSPA will be more successful
at engaging key stakeholders in the HSPA process and thus more likely to
ensure sustainability of these efforts in the long run. 
Figure 1: Performance measurement implications of setting health system boundaries
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Advantages:
• Easier to hold relative stakeholders 
to account.
• Identifies areas which relative
stakeholders have the capacity 
to make changes.
Advantages:
• Provides a more realistic view of 
all factors that influence health.
• Identifies interactions between
sectors, institutions, people that 
can influence health.
Disadvantages:
• Most factors influencing health are
not included in the framework.
• It may be difficult to disentangle the
effect health care has on outcomes
from other determinants.
Disadvantages:
• Many determinants identified are
difficult, if not impossible to change
in the short run.
• Does not provide clarity on
managerial roles.
• More difficult to assign responsibility
and hold stakeholders to account.
Medical Care Health System Boundary All Determinants
Health system performance comparison
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Yet, lack of consensus on this issue makes comparisons across frameworks 
and national performance assessments difficult. A possible solution to this
problem may be to explicitly identify different levels of the health system and
attempt to measure the contribution of each level towards the achievement 
of the performance goals. This is done in the OECD Health Care Quality
Indicators framework (Arah et al., 2006) where the representation of the 
health system through four tiers allows health care to be placed within 
a broader conceptualization of the health system as well as the economic,
social and political context of countries. While acknowledging that health care
is only one of the wider determinants of health, this structure allows health
care performance to be measured, without being subsumed within the wider
health system model. Indeed, it is advisable that regardless of how boundaries
are set, an HSPA programme should measure factors that influence the key
health system goals in order to understand how much of the observed
performance is amenable to health system influence, while also providing
stakeholders with enough information to advocate for intersectoral action. 
This solution also allows users to adapt universal measures and comparisons 
to the specific design and priorities of their own health system. We see, for
instance, a growing focus on well-being (the measurement of which is now 
in development in various agencies, including WHO), and this may or may not
feature in a given performance assessment depending on the priority accorded
it and the boundaries set for the health system. 
There is a growing consensus as to the main components of a health system.
However, the definition will necessarily vary between countries depending 
on the institutional arrangements in place. We nevertheless identify five key
elements common to all systems, namely: service provision, financing, resource
generation, leadership/governance and risk factors, which we believe should 
be included in any framework in order for it to provide a rounded picture of 
the organizational structure within which health systems operates. A clear
understanding of how these elements relate to performance is necessary in
order for users of the HSPA to relate performance back to their own system 
and identify what policy levers can be addressed to secure improvement. 
Unlike the issue of boundaries, there seems to be relative consensus on the
goals of a health system. However, there are still differences in interpretation as
to what these goals encompass. In particular, concepts such as Responsiveness,
Quality, Equity and Efficiency tend to have a variety of connotations. There is
also a lack of consensus as to how the different goals are related to one another.
For example, is access to health services an aspect of equity or responsiveness?
Is efficiency included in what we mean by quality or is quality part of efficiency?
This ambiguity leads to a lack of clarity that makes the operationalization of
these frameworks difficult and controversial (Papanicolas and Smith, forthcoming).
Policy summary
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In order for the assessments of different domains of performance to become
comparable across systems and organizations, there is an urgent need for
consensus on definitional issues. 
The key unresolved question for health system comparison in relation to system
goals is whether to treat “efficiency” as the overarching goal of the health
system, within which all comparison is to be embedded, or whether to adopt 
a more limited goal of offering fragmentary indicators of productivity, for
example in the form of unit costs of individual services. The advantages of the
former are that it offers a coherent intellectual framework, and that many of
the inputs to the health system (such as manpower) are easiest to measure at
the whole-system level. The disadvantage is that whole-system measures offer
little diagnostic information on where inefficiencies are arising.
3 How to compare key domains of performance
Performance measurement evaluates the extent to which a health system 
meets its key objectives. Most HSPA efforts focus on common dimensions of
measurement, such as health improvement or health status, responsiveness,
equity and efficiency. Population health examines both aggregate data on the
health of the entire population and health service outcomes, which focus on
the outcomes for patients. Responsiveness considers dimensions unrelated to
health outcomes such as dignity, communications, autonomy, prompt services,
access to social support during care, quality of basic services and choice of
provider. In each of these domains both the average attainment of health
systems in each domain (effectiveness) and their distribution across the
population (equity) are of interest. Often HSPA efforts also identify financial
protection as an explicit health system goal. Finally, although its exact
characterization is subject to debate, some concept of efficiency is usually 
an important dimension of performance. Table 1 considers some of these key
dimensions of HSPA efforts, considering why they are important to measure
and what the key areas of comparison are for policy-makers. 
Progress in the development of data collection techniques in the different
dimensions of health performance measures has been variable. Some areas,
such as population health, can be quite reliably captured through established
indicators, while other areas, such as efficiency, are in earlier stages of
development. Moreover, some dimensions of health systems are intrinsically
hard to capture due to their abstract or contested nature, such as multifaceted
concepts like responsiveness. Clarification of the concepts to be assessed is
therefore the first task of comparison. In terms of interpreting and constructing
measures it is then essential to be aware of the main measurement instruments
being used, whether there are gaps or disputes in the existing approaches, 
9Health system performance comparison
Table 1. Performance measurement implications of setting health system boundaries
Dimension Motivation for international
comparison
Areas of interest for
comparison
Population
health
• To facilitate a comparison 
of health within and across
countries considered from a 
broad aggregated perspective,
which includes their contributions
to many of the risk factors for
disease as well as to the delivery
of health care. 
• To facilitate a comparative
assessment of how health systems
contribute to population’s health. 
• Life expectancy
• Mortality by age group 
and condition
• Morbidity 
• Avoidable mortality
• Population risk factors
(including some measures
of inequalities to enable
comparisons) as predictors
of future population health 
Health service
outcomes
• To facilitate a comparative
assessment of how health services
assist individuals in realizing their
potential health.
• Performance of different
areas of the health system
(preventative care, primary
care, secondary care, long-
term care, mental health) 
• Health system outcomes
• Health system processes
Equity • Allows an assessment of
inequalities in health among
different population/
demographic/social groups 
within and between countries. 
• Allows an assessment of
inequalities in access and/or
utilization of services among
different population/
demographic/social groups 
within and between countries.
• Allows an assessment of inequalities
in financing of health services
among different population/
demographic/social groups within
and between countries.
• Allows an assessment of
inequalities in responsiveness of
health services among different
population/demographic/social
groups within and between
countries.
• Distribution of health
status by population/
demographic/social groups
• Distribution of access/
utilization of health
services by population/
demographic/social groups
• Progressivity of financing
system
• Distribution responsiveness
of health services by
population/demographic/
social groups
and how useful current indicators are for the purpose of assessing system
performance. Ultimately, the collection of information is useful not only for
comparative purposes but also to identify key areas of weakness and strength
internally. This section considers some of the key measures for each performance
domain as well as the related policy uses and abuses – that is, what the
indicators can and cannot tell us about system performance. 
a. Population health
Without question the main aim of any health system is to improve the health 
of the population that it serves. Thus population health is often the first area
considered when evaluating the performance of a health system, requiring
aggregated data on the health status and health improvement of the population.
Principal indicators in this area include measures such as life expectancy at
particular ages, age-standardized mortality, premature or infant mortality, 
years of life lost, disability-adjusted life-years (DALYs) – all of which capture
generic information on population health. These types of measures take a
broad perspective, which measures the effect on the health of the population
of many risk factors for disease as well as the delivery of health care. This
Policy summary
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Table 1. Performance measurement implications of setting health system boundaries
(continued)
Financial
protection
• To enable a comparative
assessment of how the health
system protects citizens from 
the financial consequences of 
ill health. 
• Out-of-pocket spending 
• Catastrophic expenditures
on health care
• Impoverishing expenditures
on health care
• Fairness of financing
Responsiveness • To facilitate a comparative
assessment of how satisfied health
systems leave the patients with
whom they come into contact. 
• Patient satisfaction
• Patient choice
• Respect of patients dignity
• Prompt attention to
medical needs
Efficiency • To facilitate a comparative
assessment that allows policy-
makers to pinpoint which parts 
of the health system are not
performing as well as they should
be, based on the experiences of
other health systems.
• Value for money 
of services
• Waste of resources
• Effective coverage
• Disease costs
perspective can be attractive from a political point of view because it
demonstrates the role that broader determinants of health play in determining
health status. However, it also creates major methodological challenges in
seeking to attribute changes in health to any particular policy.
Consequently, without discarding the broader approaches, more recent
research has focused on measuring the contribution of health care to improved
health. This has led to the development of concepts such as avoidable mortality
and the use of tracer conditions. Avoidable mortality, in its broadest sense,
includes deaths considered to be avoidable by use of appropriate and timely
medical care and those preventable by population-based interventions. It can
be further broken down into subsets of amenable mortality which refer to
conditions where “it is reasonable to expect death to be averted even after 
the condition develops” and preventable mortality which includes deaths 
from conditions that can be prevented by population-based interventions, but
where the contribution of health care may be limited once the condition has
developed (Nolte & McKee, 2004). Recent work in this area considers how
avoidable mortality can be measured in different countries, and how metrics
can be used in comparative analyses (Box 2). 
11
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Box 2. Avoidable Mortality in European Health Systems (AMIEHS) 
Funded under the European Union Public Health Programme, the AMIEHS
project, led by Erasmus Medical University and coordinated jointly with the
London School of Hygiene & Tropical Medicine, brings together partners in seven
EU countries with the aim of creating better comparable indicators with which 
to measure the contribution health care makes to population and how this varies
among countries. The project aims to develop a set of avoidable-mortality-based
indicators that can be used in future surveillance of the performance of health
systems in Europe.
The project aims to undertake the following initiatives which will assist policy-
makers and researchers with the understanding, measurement and use of
avoidable mortality indicators in Europe: 
• to conduct a systematic review of the literature to assess to what extent causes
of death can be considered avoidable;
• to gather in-depth information on the introduction of medical innovations in
seven countries;
• to develop a set of avoidable mortality-based indicators that is agreed upon;
and
• to prepare an electronic atlas of avoidable mortality in 25–30 countries in
Europe. (http://survey.erasmusmc.nl/amiehs/maps/J45_J46/atlas.html)
Source: http://amiehs.lshtm.ac.uk/
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Tracer conditions are based on the premise that carefully selected health
problems can provide insights into the more general performance of elements
within the overall health system (Nolte, Bain & McKee, 2009). Table 2 considers
the main types of indicators used to measure population health as well as 
their policy uses and abuses; what the indicators can and cannot tell us about
system performance.
As evident from Table 2, many of the existing measures of population health
fail in their simplest form to distinguish the contribution of health care from
extraneous factors. Moreover, all indicators still suffer from a number of
methodological problems that need to be addressed in order to make
international comparisons more meaningful. Important issues involve availability
and coding of data, particularly of data on cause of death where there are
Table 2. Main indicators for population health
Main indicators Policy uses Limitations
Generic indicators:
e.g. life expectancy,
age-standardized
death rates 
These are broad indicators
of health service delivery
and achievement of 
desired population health
outcomes. 
• Broad indicator of health;
• Mask contributions of specific
causes;
• Exclude morbidity; 
• Need further disaggregation
by age and cause.
Age/disease-
specific indicators:
e.g. infant 
mortality rate,
perinatal mortality;
age-specific
mortality, cancer
five-year survival
Allow more detailed 
analysis of specific 
outcomes of the quality 
of health care.
• Susceptible to variations in
recording and reporting
practices.
• Rely on precise definitions not
always adhered to in practice
(perinatal mortality).
• Capture influence of broader
health determinants.
• Are based on small numbers.
• Complex interpretation of
underlying causes.
• Need to be interpreted in
context of risk factor and
disease prevalence, and
policies in other sectors.
• (Cancer survival) has to be
viewed alongside mortality
and incidence rates. 
13
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Table 2. Main indicators for population health (continued)
Main indicators Policy uses Limitations
Morbidity indicators:
e.g. health survey
data, incidence
notifications, health
service utilization 
At present morbidity data 
is of limited use in assessing
the contribution of health
care to population health
but there is great interest 
in emerging initiatives to
develop registries for
specific conditions, which
focus on health outcomes
and service delivery aspects.
• Reporting bias (health survey
data).
• Non-specific to health care
interventions (health survey
data).
• Variations in notification
requirements and diagnostic
practices.
• Data coverage (often excludes
private sector).
• Representativeness
(utilization only shows people
who accessed the health
service). 
Summary indicators:
e.g. Health-adjusted
life expectancy
(HALE), DALYs 
Allow a more rounded
picture of population health
assessment that takes into
account both mortality and
morbidity of populations.
• Controversial methodology
(age and disability
weightings).
• Limited availability of the
required health status data,
especially over time. 
Indicators measuring
the contribution of
health care: 
e.g. avoidable
mortality (AM),
tracer conditions 
Selected mortality-based
indicators combined 
with supplementary
techniques (such as tracer
methodology) allows 
the exploration of the 
individual aspects of 
health service delivery
process and highlight
potential gaps 
and weaknesses.
• Aggregate measure requiring
further disaggregation (AM). 
• Variations in list of amenable
causes and age limits (AM). 
• Time lags for outcomes of
specific interventions (AM).
Source: Adapted from Karanikolos et al., forthcoming.
Policy summary
14
problems of comparability among countries and over time. Coding is also
influenced by changes among versions of the International Classification 
of Diseases and national coding rules, often reflecting whether automated
coding is used or not. There are also large gaps in the availability of evidence 
on the effectiveness of treatments in reducing mortality, which is rarely an
outcome of randomized trials. Especially in Europe, there are no internationally
comparable surveys of clinical practice and health care experience. In the
future, more investments should be made in the development of internationally
comparable clinical databases providing risk-adjusted information on individual
outcomes of treatment. In the meantime, policy-makers looking to understand
changes in health status of their population might consider making greater use
of tracer conditions, through which the everyday experiences of those in need
of care can be understood and addressed.
Not all of the problems facing population health indicators can be readily
resolved, and so it is important to understand limitations and take them 
into account when interpreting data. Some of the most important issues 
to consider in the interpretation of data are the difficulty in attribution, 
not only from other factors that can influence health status, but also from
distinguishing changes in the ability of health systems to prevent death 
once disease has occurred from changing incidence of that disease, thus
complicating attribution. Moreover, observed changes in mortality from
particular causes, even if not due to artifact, can reflect changes in any one, 
or a combination of innovation, coverage or quality. These can be difficult to
distinguish. Finally, in the analysis of national policy, it is important to consider
the varying and often diffuse time lags between the introduction of a policy 
or treatment innovation and a change in outcome. 
b. Health services outcomes
Although the main objective of health services is ultimately to assist individuals
in realizing their potential health and thus promote the health of the
population, measuring the contribution of health services to health outcomes
involves quite distinct challenges. For example it is essential to ensure that the
services being compared are directly comparable, and that proper adjustment 
is made for differences in the populations being served. Direct indicators of 
the contribution of health services to health status are available in the form of
health service quality measures, such as standardized hospital mortality rates
and numerous disease-specific health outcome measures. To date, outcome
measures in widespread use capture only a limited set of dimensions of the
broad “health concept” and tend to focus on mortality (case fatality rates,
hospital standardized mortality rates) adverse events and complications (patient
safety indicators) as well as readmissions and avoidable admissions (hospital
care, mental health care, primary care). Outcome measures in areas such 
as disabilities and discomfort are far less prevalent. For the purposes of
international comparison in high-income settings, the OECD quality indicators
project is an important resource (Box 3). While such measures offer some
indicators of the performance of individual organizations (after suitable
adjustment for case-mix and other contextual circumstances), international
comparison can be complicated by different organizational settings and
reporting conventions.
Routine use of patient-reported outcome measures (PROMs) has recently 
been introduced in England, and experience there will indicate the potential
they offer in addressing some of the existing measurement gaps. The uptake 
of PROMs for routine purposes has hitherto been hindered by comparability 
issues especially in content validity and the relative importance of different
criteria. Some disease-specific questionnaires upon which PROMs are based 
are not only considered costly and time-consuming but may also be intrusive
and burdensome to patients, potentially jeopardizing the professional–client
relationship. However, simpler generic instruments such as the EQ5D in 
England have secured high response rates both before and after surgery. 
In many performance measurement initiatives, measures of health care process
are used in preference to more direct measures of outcome. These have the
virtue of administrative convenience, can be measured immediately, and are
Health system performance comparison
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Box 3. Health Care Quality Indicators (HCQI) 
The HCQI project, led by the OECD, was initiated in 2001 with the aim of measuring
and comparing the quality of health service provision in the different OECD
countries. Over the years the HCQI project has grown into a robust source 
of internationally comparable data on the quality of care as well as a forum 
for policy-makers and researchers to assist in the improvement of quality
measurement. The project has focused on producing comparable indicators in 
key areas of health care such as primary care, acute care, mental health care,
cancer care, patient safety and patient experience. 
Most data are collected from administrative databases, registries and population
surveys. Following the compilation of the data considerable efforts are undertaken
to methodologically refine the data assessment and collection procedures, such as
assessment of data quality, refinement of technical specifications, enhanced data
collection guidelines and questionnaires and the harmonization of approaches 
to age/gender standardization. Currently there are nearly 40 indicators that are
routinely collected and reported for Member States every two years. 
Source: OECD, 2010.
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easier to attribute directly to the efforts of the health services. Furthermore,
they reflect compliance with what is considered good practice and may
therefore be a better measure of assessing the quality of health care providers
when the processes measured are known from research evidence to lead to
good patient outcomes. In contrast, more distant outcome measures may be
influenced by many factors other than the quality of care alone. However,
process measures may ignore the ultimate effectiveness or appropriateness of
the intervention, and their use pre-judges the nature of response to a health
problem, which may not be identical in all settings. Judging health services by
adherence to standards or guidelines based on single diseases can therefore 
be misleading, especially in situations where health services are dealing with
patients with multi-morbidities. 
One of the main methodological issues in the development of outcome
indictors is data quality and availability. Any further development in measuring
health outcomes therefore depends on the enhancement and expansion of
current data sources. This is likely to entail more widespread use of Unique
Patient Identifiers to link various data sources, the use of secondary diagnoses
codes, present-at-admission codes and standardization of procedure codes. 
This is a prerequisite for increasing the potential for case-mix adjustments 
for outcome measures and the further development and testing of new
measures such as PROMs and other measures that can use Electronic Health
Records and patient surveys as their main data source. Contingent on privacy
and data protection regulation and supported by the necessary research and
development to test reliability and validity, health outcome measures, capturing
health services outcomes, will become an increasingly important part of health
system performance assessment.
Health system performance comparison
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Table 3. Main indicators for health service outcomes
Main indicators Policy uses Limitations
Hospital outcome
indicators: e.g. Hospital
Standardized Mortality
Rates (HSMRs), case
fatality rates for Acute
Myocardial Infarction
(AMI) and stroke,
patient safety 
indicators and hospital
readmission rates
Hospitals are considered
by many policy-makers
to be the epicentre 
of the health care
system – these
indicators consider the
contribution hospitals
make to health
outcomes over time. 
• HSMRs do not account for
preventable deaths and the
observation that a majority 
of deaths are unavoidable.
• Differences across hospital
systems and records make
comparability across hospitals
and countries difficult.
• Lack of data collection at the
individual level, and lack of
supporting information for
which to case-adjust indicators
pose issues for reliability and
comparability of indicators. 
• Readmission indicators pose
problems of comparability due
to different definitions of time
frames and type of readmission
investigated as well limitations
in case-mix. 
• More information is needed 
to determine the actual
relationship between
readmissions and the quality 
of care.
Patient-reported
outcome indicators
(PROMs): e.g. SF-36,
EQ5D
PROMs are useful as
they are not only able
to capture and regularly
assess aspects of health
that are of most
concern to patients 
but are argued to 
be essential for 
the assessment of
patient need and
communication
between patient 
and provider in 
routine care.
• Individualized instruments are
very time-consuming and often
involve complex interviews.
• Uptake largely hindered by
comparability issues, especially
in content validity and the
relative importance of different
criteria.
• Questionnaires are considered
costly and time-consuming.
• May be regarded as “soft
information” by some
stakeholders.
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Table 3. Main indicators for health service outcomes (continued)
Indicators for long 
term care: e.g. process
indicators, client
experiences, nursing-
related outcomes 
(bed-sores, patient
falls), outcomes of
targeted illnesses
(diabetes, dementia,
etc.)
Measuring the quality
of long-term care
services is of high
importance given 
the global ageing
population trend and
the present morbidity
and disability patterns
associated with chronic
diseases.
• Complexity of chronic care, and
different levels and settings of
service provision hamper the
identification of possible
quality indicators and create
difficulties in standardized 
data collection and reporting
conventions. 
• It is hard to pinpoint medical
outcome measures to the
performance of long-term care
institutions, as a result nursing-
related indicators are usually
the only ones used.
• Outcomes of targeted illnesses
(such as avoidable admissions
for diabetic patients) may 
be as much an indicator for
other areas, such as GP or
specialist care.
Indicators for primary
care: e.g. avoidable
events, preventable
admissions, process
indicators
The significance of
primary care lies in 
its effectiveness in
preventing illness 
and death and in 
its association with 
a more equitable
distribution of health 
in populations.
• The wide variation in payment
and contractual organization
for primary care services across
countries inevitably translates
into differences in the scope 
of data collection possible.
• Despite progress in the
international collection of data,
the most robust source for
deriving indicators in primary
care remains to be hospital
administrative data. As such,
they do not provide a complete
assessment of a primary care
system’s quality of care.
• Collection of avoidable
admissions and adherence to
processes relating to specific
clinical areas (e.g. diabetes,
asthma, COPD) are sufficiently
relevant to policy and
scientifically sound for potential
use in international data
collection but still of limited
availability across countries.
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Table 3. Main indicators for health service outcomes (continued)
Main indicators Policy uses Limitations
Indicators for mental
health: e.g. rates of
unplanned readmission
for schizophrenia and
bipolar disorder
Mental health problems
are common, affecting
all sections of society
and every age group.
• Variation of organization
across countries makes the
assessment of the quality of
mental health care services for
evidence-based policy difficult.
• The availability of national
indicator data suitable for
international comparison is
extremely limited due to the
complex nature of mental
health disorders, the
differences in diagnostic 
and therapeutic practices,
institutional government
barriers as well as differences 
in the coding and reporting 
of mental health care within
and between countries.
Indicators for
preventative care:
e.g. screening rates
Screening is of great
interest to policy-
makers because of the
significant bearing it
may have on survival
prospects.
• There are many methodological
issues relevant to the data
collection for and comparability
of cancer screening indicators
in combination with other
cancer outcome information
such as five-year survival rates
and cancer mortality rates,
including data sourcing 
(e.g. surveys versus registries),
heterogeneity in cancer 
survival and screening
reporting periods, age
standardization, the extent 
to which country data is
nationally representative, 
and, perhaps most importantly,
a lack of cancer staging data. 
Source: Adapted from Klazinga & Li, forthcoming.
c. Equity
The exact specification and importance of equity objectives is for individual
nations to determine. We are concerned with ensuring that stakeholders are
aware of the tools to use in order to measure their performance with regards 
to the policies they have chosen to pursue. 
The principle of equity in health is the principle of equal (or equitable) health
outcomes (for example, quality-adjusted life expectancy). When analysing
inequalities in health outcomes at the individual level, different health outcome
measures have been used in the literature, from subjective measures of health,
such as self-assessed health, to more objective measures of health such as
biological markers (Box 4). Summary measures of population health can be
used, such as: disability-free life expectancy (DFLE), HALE and DALYs by
socioeconomic status (SES). However, data linkages often make this approach
problematic. Second, it is possible to apply mortality-based indicators, such 
as life expectancy, total mortality rate and infant mortality rate by SES, which
requires linkage between death registries and socioeconomic status information.
Third, morbidity-based indicators such as self-rated health by SES or self-rated
disability by SES can be used, feasible for international comparison studies as
relevant data are often included in health surveys.
Various methodologies can then be used to investigate disparities in health
among different groups of the population. When investigating socioeconomic
Policy summary
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Box 4. Measures of health outcomes
Most subjective
Most objective
Health indicator
Self-assessed health
Chronic illness
Limited activities
Symptoms
Depression scale
Activities of daily living
Diagnosed conditions
Body Mass Index (reported)
Biomarkers
Mortality
inequalities in health, there are several groups of methods that can be applied
to determine absolute inequalities in health, such as the Gini coefficient.
Alternatively, regression methods can be used to derive measures of association,
such as the odds ratios. Finally, more advanced methods that create indices
based on ranking of socioeconomic variables may be used, such as the
Concentration Index. This decomposes overall inequalities in health by the 
main contributory need and non-need variables (Wagstaff, van Doorslaer &
Watanabe, 2003; O’Donnell et al., 2008). This methodology can be extended
further to take into account the longitudinal perspective, by measuring long-
term income-related inequalities in health (Jones & López-Nicolás, 2004). 
Yet research on health equity is concerned not only with equal or equitable
health outcomes, but also with equity in health care utilization/access, health
care financing and responsiveness (O’Donnell et al., 2008). In the case of equity
in access or utilization to health care, the main interest focuses on measuring
whether individuals with the same level of clinical need are receiving the same
level of health care, a horizontal equity principle. Many of the measurement
challenges in this area derive from difficulties in conceptualization and
measurement of the concepts of access and need (Allin, Hernández-Quevedo 
& Masseria, 2009). The main methods used for measuring inequity in access 
to health care for cross-country comparison studies are: a simple comparison 
of rates of access for different groups of the population, the use of regression
methods such as adjusted odds ratios, which are a measure of association, 
and the Gini-like coefficients such as the horizontal inequity index. 
Financing systems can take three broad forms: progressive (payments are an
increasing proportion of ability to pay, such as income taxes), proportional
(payments represent a constant proportion of ability to pay, such as payroll
taxes) and regressive (payments are a decreasing proportion of ability to pay,
such as out-of-pocket payments). When measuring equity in finance, the
interest focuses on the extent to which health care payments are related to
ability to pay. In particular, the vertical dimension of equity is fundamental, in
order to understand the extent to which those with unequal ability to pay do
pay differently for health care. In order to measure vertical equity, progressivity
indices (Wagstaff et al., 1999) have been designed, such as Lorenz curves and
Gini coefficients, Concentration curves and the Kakwani index.
Responsiveness of the health care system has been defined as the extent 
to which health services are aligned with user preferences in domains 
such as patient autonomy, choice and quality of amenities (see section e,
Responsiveness). Methods are being developed to measure systematic
differences in responsiveness by social group (see Valentine et al., 2009). The
main challenge is the continuing debate over how to define and conceptualize
responsiveness, as discussed below.
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21
Policy summary
22
Table 4. Main indicators for equity
Main indicators Policy uses Limitations
Equity in health
outcomes: i.e.
distribution of
health among
different groups.
Constructed from
indicators of health
status and
socioeconomic
variables.
The main goal of the
health systems would
be to decrease the
gap between health
outcomes that are
systematically related
to socioeconomic
status and hence,
focusing on reducing
socioeconomic
inequalities in health
outcomes is the 
usual performance
measure in the health
systems. There is also
substantial evidence
on inequalities in
health across many
population groups
(region, ethnicity,
gender, language).
• Measures are limited by the
availability of outcome indicators
available as well as their linkage 
to socioeconomic variables. 
• Numerous surveys include outcome
and socioeconomic information, but
the reliability on subjective measures
of health status raises important
methodological challenges that
relate to the potential reporting 
bias that could appear.
• Longitudinal data is lacking,
especially for a comparative analysis,
making it difficult to understand
changes over time. 
• Objective measures such as
physicians’ assessments or hospital
stays are best for comparative
purposes. However, the availability
of objective measures of health, 
such as biomarkers, is limited.
• Biomarkers may still be subject 
to bias and are not included in
longitudinal data. 
• Standardization of biomarker data
collection across countries is also 
an issue.
Equity in access or
utilization: 
i.e. distribution of
access or utilization
of health care for
equal amounts of
need among
different groups. 
Constructed from
indicators of access,
utilization, need,
unmet need and
socioeconomic
variables. 
The main focus of
equity of access or
utilization is to
measure whether
individuals with the
same level of need
are receiving the
same level of health
care, and thus to
determine if
inequalities are
unavoidable. 
• Often the terms “access” and
“utilization” are used interchangeably,
implying that an individual’s use of
health services is proof that he/she
can access these services. However,
utilization is not equivalent to access.
• Utilization and need are often
captured by survey information,
which can suffer from reporting 
bias as well as comparability issues
across countries. 
• Little data is collected longitudinally,
and there are large gaps on data
that inform on environmental factors. 
23
Health system performance comparison
Table 4. Main indicators for equity (continued)
Main indicators Policy uses Limitations
Equity in financing:
i.e. distribution 
of financing of
health care among
different groups. 
Constructed 
from indicators 
of expenditure 
and income. 
The main focus on
equity of financing 
is to determine
whether the health
system is progressive
(namely, how much
larger payments are
as a share of income
for the poor than for
the better-off).
• The tabulation of average incomes
and health care payments by 
income groups have been used 
in the literature. However, this
methodology is not able to establish
how much more progressive is one
system than other. 
Equity in
responsiveness:
i.e. distribution 
of responsiveness
among different
groups.
Constructed from
information on
responsiveness and
socioeconomic
indicators.
Responsiveness of the
health care system
has been defined as
the extent to which
health services are
aligned with user
preferences in
domains such as
patient autonomy,
choice and quality 
of amenities. Equity
in this area considers
the distribution of
this health system
goal across groups 
in the population.
• There is still lack of clarity on 
what is meant by responsiveness,
resulting in numerous different,
conflicting measures within and
across countries. 
Source: Adapted from Hernández-Quevedo, Papanicolas & Machenback, forthcoming.
d. Financial protection
Financial protection is a multidimensional concept that usually refers to the
extent to which people are protected from the financial consequences of 
ill health (WHO, 2000). Such protection is a key objective of health systems
worldwide. The most appropriate set of policies for improving financial
protection will depend on the particular context. It is thus of foremost
importance to have accurate means of measuring the extent of financial
protection and of understanding the determinants of financial risk in a
particular health system, so as to aid the identification of suitable policy 
levers. Useful measurement tools have been developed with this aim. 
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Financial protection can be observed in several forms, such as high out-of-
pocket payments for health care or lack of access due to financial barriers. 
The multidimensional nature of financial protection has made it difficult 
to develop a single indicator capturing the full extent to which people are
financially protected from health shocks. Instead, partial measures of the
incidence and magnitude of households’ direct payments for health care 
usually form the basis of metrics for financial protection assessment and 
system comparisons. The emphasis so far has been on the incidence of
(1) “catastrophic” health payments, relative to some threshold of household
income, and (2) “impoverishing” health payments, relative to some 
pre-defined poverty line. More recent literature has focused on the incidence
and magnitude of user payments for health care, mainly out-of-pocket
expenses (and sometimes only these), to get at the issue of the extent of
financial protection in a health system.
Such metrics, based on information provided by household surveys, fails 
to recognize that inability to pay may deter access to necessary care, hence
resulting in very low or zero health expenditures reported (Moreno-Serra,
Millett & Smith, 2011). The typically right-skewed distribution of health 
care spending observed in household surveys (with a high number of zeroes)
underlines, among others, the problem of inadequate risk-pooling, and
suggests that many households worldwide experience major financial barriers
securing access to health services. While this may be linked to equity of 
access, it is also an important indicator of lack of financial protection per se. 
In addition, conventional measures of financial protection for performance
assessment cannot say much about the specific drivers of financial risk in a
health system. This has led to suggestions that some indicators of coverage 
for certain basic health care treatments should be used to complement the
information provided by currently used financial protection metrics (see, for
instance, WHO, 2010). 
Cross-country studies have normally focused only on comparing the measured
incidence of catastrophic or impoverishing spending. The limited scope of 
such studies has meant that conclusions about system-wide determinants 
of differences in financial protection levels across countries have often been
based mostly on descriptive or anecdotal evidence.
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Table 5. Main indicators for fairness in financing
Main indicators Policy uses Limitations
Catastrophic and
impoverishing
health payments
Catastrophic spending
indicators can offer a
useful picture of the
extent to which citizens
in a health system suffer
hardship due to the costs
of health care services.
Impoverishing health
payment indicators allow
system comparisons in
terms of the number 
of people being pushed 
into poverty, relative 
to a minimum living
standard, due to illness. 
• Provide only limited insights about
what the major determinants of
inadequate financial protection 
are in a given context. 
• Do not inform as to whether 
factors related to financial barriers
of access to health care play a
relevant role for the measured
extent of financial protection and,
if so, which individuals are more
affected by such barriers.
• Lack of work investigating the
various aspects related to access to
health services as determinants of
financial protection levels means
that the comparison of incidence 
of catastrophic or impoverishing
spending across countries can only
result in speculative conclusions
about system-wide determinants of
differences in financial protection
levels across countries.
Out-of-pocket
payments
A simple strategy to gain
some insight into how 
far citizens in a health
system are protected
against the financial
consequences of 
illness is to look at the
contribution of private
health spending to the
financing of the system.
• Cross-country examinations of 
the relative importance of out-of-
pocket expenses for funding the
health system can convey helpful
insights for performance
comparisons of financial risk. 
• Measuring and comparing the
actual extent of financial protection
across health systems would require
the analyst to examine micro-data
relating households’ out-of-pocket
health expenses to some metric in
terms of their living standards.
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Table 5. Main indicators for fairness in financing (continued)
Index of fairness 
of financial
contribution 
(WHO, 2000)
The notion of 
fairness of financial
contribution
developed in the
World health report
2000 is based on the
premise that a fair
health system ensures
that households
make health care
payments according
to their ability to pay
rather than risk of
illness, hence being
protected against 
the risk of falling 
into poverty – or
being deterred from
seeking care –due 
to health care costs.
• The indicator is unable to
discriminate between countries
where health payments are
progressive or regressive; the 
extent to which inequalities are 
due to horizontal inequity, vertical
inequity; and between different
proportions of national income
going to the health care system.
Source: Adapted from Moreno-Serra, Thompson & Xu, forthcoming.
e. Responsiveness
The World health report 2000 on the performance of health systems proposed
responsiveness to citizens’ expectations as a central and distinct goal. It pushed
forward a debate that frames responsiveness as a valued and desired outcome
of health system interventions regardless of the extent to which those
interventions lead to health improvement (WHO, 2000). Health services reforms
in many countries have been placing increased explicit emphasis on improving
responsiveness to patients and increasing both population and patient satisfaction.
In preparation for the World health report 2000, an extensive literature review
covered disciplines including sociology, anthropology, ethics, health economics
and management in order to elicit what people value most in their interactions
with the health system (De Silva, 2000). This was used to select a common 
set of seven dimensions (or domains) that characterize the concept of
responsiveness, which was subsequently augmented by an eighth, as
summarized in Table 6. Four are grouped under “respect for persons” 
(dignity, confidentiality, autonomy and clarity of communication) and four
under “client orientations” (prompt attention, quality of basic amenities, 
access to family and community support, and choice of health care provider).
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There is still uncertainty as to what dimensions are included in the domain of
responsiveness, and this lack of clarity leads to variation in the areas measured.
The consequent variations in results reflect the different approaches towards
the selection of weights, domains and indicators (i.e. surveys capture different
phenomena); differences in the methodology of data collection (e.g. sampling)
27
Table 6. WHO dimensions of responsiveness and questions used to measure it in the
World health report 2000 and two WHO population surveys
Dimension World health 
report 2000:
grouping and
weighing (results
based on interviews
with experts)
Multi-country
survey study
2000/2001
World health
survey 2002
Respect for persons
Dignity: Respectful treatment
and communication
16.7% 4 questions 2 questions
Confidentiality of personal
information
16.7% 2 questions 2 questions
Autonomy: Involvement in
decisions
16.7% 3 questions 2 questions
Clarity of Communication Not included 4 questions 2 questions
Client-orientation
Prompt attention: Convenient
travel and short waiting times
20% 2 questions 2 questions
Quality of basic amenities:
Surroundings 
15% 3 questions 2 questions
Access to family and community
support: Contact with outside
world and maintenance of
regular activities
10% 3 questions 2 questions
Choice of health care provider 5% 3 questions 1 question
Source: Busse, forthcoming. 
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and interpretation; as well as actual differences in health systems’ levels 
of responsiveness. 
Both responsiveness and satisfaction are terms that aim to capture the degree to
which health systems, or their components, are successful in responding to the
expectations of the general population or a population subgroup of patients. 
A wide range of methods has been used to attempt to measure responsiveness
and/or satisfaction over the last decades, most visibly work by Blendon et al.
(1990); population satisfaction questions in Eurobarometer surveys since 1996
(European Commission, 1996, 1998, 1999, 2000, 2002); the Picker Institute’s
development of patient experience surveys (Coulter & Cleary, 2001, Jenkinson,
Coulter & Bruster, 2002); the EUROPEP instrument to assess general practice
(Grol et al., 2000); the World Health Report 2000 (WHO, 2000), as well as work
by the Commonwealth Fund (Schoen et al., 2007). 
Responsiveness and satisfaction are distinct but related concepts. The WHO
definition refers to “responsiveness to the legitimate expectations of the
population for their interaction with the health system”. This implies that there
can be illegitimate or unjustified expectations too, but the instrument only
captures those that are regarded as legitimate. The “satisfaction of the overall
population with the health system” may be influenced by other expectations
(which experts or policy-makers may consider illegitimate) and factors outside
the direct control of the health care system. Satisfaction is likely to be more
dependent on expectations than responsiveness surveys, so higher satisfaction
levels may to some extent be a function of lower expectations. WHO used a
vignette approach in its World Health Survey in order to correct for different
expectations, but this approach was dropped due to the complex data and
analytic requirements (Rice, Robone & Smith, 2010).
In principle, the concept of population satisfaction with the whole health
system is straightforward. In fact, it is difficult to measure satisfaction as the
answers to all questionnaires depend on the specific wording of the question
asked as well as the answer categories provided. The answers depend
particularly on factors not yet well-understood, that is (1) the context in 
which a survey takes place, for example, coloured by recent media coverage 
of scandals, fraud or underprovision of services; (2) no differentiation between
the system as a whole and certain subsectors about which the respondent may
be more knowledgeable; or (3) the inability to differentiate between the health
care system and government in general. Busse et al. (2011) provide an overview
of different population surveys used over recent decades. 
Another source of information in this area is surveys of patients’ experience
with treatment by particular providers. Such surveys relate more to
responsiveness than to satisfaction as they are based on (1) predetermined
Health system performance comparison
domains and (2) patients’ actual health service encounters. Widely used surveys
are available for inpatient, outpatient, general practitioner, maternity, mental
health, community and emergency care, as well as for specific groups of
patients, for example those with diabetes, heart disease or cancer.
In summary, different questionnaires with different items in relation to
responsiveness sometimes lead to inconsistent or contradictory results and may
be difficult to interpret. Overall, the lack of consensus on concepts and metrics
makes it hard to draw clear conclusions on the differences between health
systems, and even less about the health system strategies that may explain
them. Progress in this area needs to be made initially on the conceptual front
and, once more clarity is obtained, regarding what needs to be measured
before more consistent indicators can be produced within and across countries.
f. Efficiency
Efficiency indicators serve as a summary measure of the extent to which the
inputs to the health system, in the form of expenditures and other resources,
are used wisely to secure the goals of the health system. Economists often
make a distinction between two types of efficiency: allocative efficiency and
technical efficiency. Allocative efficiency indicates the extent to which limited
resources are directed towards producing the correct mix of health care outputs
in line with the preferences of payers. 
Indicators of allocative efficiency exist at the micro-level (are the “right”
treatments being used) or at a macro-level (is the appropriate level of resources
dedicated to health care, relative to other sectors of the economy, given
prevailing societal values). Allocative efficiency can also be considered within
the health care system at an intermediate level to examine whether the correct
mix of services is funded, such that attainment of system objectives such as
health outcomes is maximized for a given aggregate level of expenditures.
In contrast, technical efficiency indicates the extent to which the system is
minimizing costs in producing its chosen outputs, regardless of the value 
placed on those outputs. Whereas allocative efficiency assesses whether the
system is producing an appropriate mix of outputs, technical efficiency makes
no judgement on how much the outputs are valued by society, and is
concerned solely with any “waste” in creating those outputs. 
Productivity is a concept that is closely related to efficiency. It is concerned with
the ratio of an input (or aggregation of inputs) to an output (or aggregation 
of outputs). Productivity measures take no account of whether the observed
variations in output can be attributed solely to the entity under scrutiny.
Productivity measures are therefore usually more simplistic than efficiency
measures, and may be less useful as a diagnostic tool. There have been
29
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considerable efforts to apply the methods of efficiency analysis (regression
analysis, stochastic frontier analysis and data envelopment analysis) to infer
comparative efficiency of various aspects of health systems. Such techniques
seek to build production functions by explaining justifiable variations in
performance between the entities under scrutiny, and to characterize the
unexplained residual as “inefficiency” (Street & Hakinnen, 2009). Although
conceptually attractive, there are few examples of such methods being used 
in earnest by decision makers. 
Comparative efficiency indicators are constructed using health care system 
data from the various stages of production processes, such as conversion of
hospital inputs (capital, manpower, pharmaceuticals, devices, etc.) into valued
outcomes, in the form of health improvement. The precise types of data used
depend on availability and the scope of the entity under scrutiny. Examples of
data from the various stages include:
• costs: sometimes disaggregated into categories, with or without 
overheads allocated;
• physical inputs: such as measures of labour (staff employed, by category)
or capital (e.g. hospital beds);
• activities: such as procedures undertaken, days of care provided, 
diagnostic tests ordered, community visits made;
• physical outputs: such as episodes of care or patients cared for;
• outcomes: such as quality-adjusted life-years (QALYs), avoidable deaths, 
or other health status data.
Almost all efficiency indicators are constructed as a ratio of one of these
measures (for example costs) to another (such as the related activities), offering
an indication of the extent to which resources have been used efficiently along
some or all of the production pathway. 
There are various challenges involved in constructing meaningful efficiency
indicators. A fundamental analytic challenge is to control adequately for the
range of environmental factors, policy constraints, population characteristics and
other factors that may be important constraints on productivity improvement.
Even after undertaking some adjustment for such constraints, it is important 
to exercise caution in attributing all of the observed variation to variations in
efficiency. Furthermore, the assignment of inputs and associated costs to specific
health system activities can be problematic from an accounting perspective,
often relying on arbitrary accounting rules or other questionable assignments.
In summary, it may be difficult to ensure that the output being captured is directly
and fully dependent on the inputs included in the measurement. Table 7
presents a sample of efficiency indicators commonly used by policy-makers,
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Table 7. Sample of efficiency indicators
Indicator What is it? What are the assumptions and what
does it ignore?
Cost–effectiveness of
certain intervention
Cost per QALY Assumes average costs of providing
intervention do not change with
scale; major data constraints.
Emergency
department (ED)
visits that could have
been seen in less
invasive settings 
The proportion of 
ED visits that could
have been seen in 
a different, less costly
setting
Ignores quality of care. Depends 
on definitions. 
Average length 
of stay
The number of days per
hospital inpatient stay
Cases are identical, both in terms of
outcomes and in terms of intensity.
Unit costs Estimates of costs Assume uniform treatment, uniform
accounting methods, ignore quality.
Case-mix adjusted
cost per episode of
care
The average costs for
treating a certain type
of condition
Cases are identical, both in terms of
outcomes and in terms of intensity;
assumes uniform treatment, uniform
accounting methods.
Duplicate medical
tests
The number of tests
that are done more
than once for the 
same patient
Assumes any duplicate test is an
inefficiency regardless of situation.
Share of total
expenditures spent
on administration
The percentage 
of total health
expenditures dedicated
to administration
Assumes that greater share of 
admin expenditure is inefficient
without accounting for scale. 
Highly dependent on accounting
methods used.
Labour hours per
episode of care
The number of hours
per case-mix adjusted
episode of care
Assumes patients require the same
intensity of care; difficult to measure
accurately across a large sample;
affected by health system design 
as well as efficiency.
Share of health
worker hours spent
treating patients
The percentage of
health worker hours
spent treating patients
Assumes patients require the same
intensity of care; difficult to measure
accurately across a large sample;
assumes time not spent with patients
is unproductive.
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Table 7. Sample of efficiency indicators (continued)
Indicator What is it? What are the assumptions and what
does it ignore?
Disease costs The average cost 
per case of treating 
a certain disease
Can be difficult to calculate 
without linking patient data 
across providers. Assumes uniform
case-mix. Highly dependent on
accounting methods used.
Effective coverage The share of actual
health gains achieved
relative to maximum
potential health gains
for an intervention
Difficult to measure need 
and quality.
Source: Cylus & Smith, forthcoming.
highlighting important assumptions that these indicators make. While efforts
should be undertaken to improve accounting and data collection efforts, there
is a limit to what can be achieved analytically in this domain, and policy-makers
should make themselves familiar with the limitations of any indicators used. 
4 Future directions and conclusions
If undertaken carefully, health system performance comparison offers a powerful
resource for identifying weaknesses and suggesting relevant reforms. The progress
that has been achieved is impressive, both in the scope of areas for which
comparable international data on health are now available and in the degree to
which comparability has been improved. However, the science of international
comparison is at a developmental stage. Policy-makers therefore need to be
made aware of both the strengths and limitations of health system comparison. 
There are various ongoing initiatives and developments that have the potential
to benefit further international comparisons. One very large area of development
is that of information and communication technologies (ICT), often described
within the EU context in particular as “e-health”. This area has the potential 
to greatly improve data collected at the system level. Moreover, as increasing
numbers of people seek health care outside their own country, there is a
growing incentive for better comparability at the international level (Busse 
et al., 2011b). However, certain challenges remain in securing comparability
across conceptualizations, definitions and indicators in the international setting
(Table 8). 
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A particularly European issue, relevant to all domains of performance, is that
although international comparisons are historically made between whole
countries, in most European countries health systems are now organized
primarily at a regional level. Therefore, comparisons at national level, without
some regional breakdown, are inherently limited in their utility, as they may
conceal wide internal variation. Some progress has already been made in
developing and validating regional-level comparisons.
An important further consideration is that many of the indicators used for
international comparison contain implicit value judgements that should be
subjected to careful scrutiny. For example, concepts such as health outcomes,
disability weights, responsiveness and equity assume a certain set of values as
to what constitute the objectives of the health system, and what their relative
importance is. Policy-makers at the very least need to be aware that certain
value judgements have been made in how indicators are selected, measured
and presented.
The presentation of comparisons has hitherto not been especially helpful for
policy-makers. Neither the bald presentation of league tables nor a detailed
narrative of caveats is well suited to securing appropriate policy responses. 
Two types of risk arise from poor presentation of comparisons: uncritical
acceptance of results and potentially costly and inappropriate reforms of the
health system; or rejection of the comparisons as inadequate, and a consequent
lost opportunity to reform. In either case, the key issue is the need to focus on
the policy-maker’s action, and to ensure that it is well-informed, acknowledges
the inevitable uncertainty, and is proportionate. For this to be achieved, it will
usually be necessary to present indicators of health system environmental
factors, functions and capacity alongside performance measures. These will
assist in explaining the reported performance, and suggesting policy responses.
The key requirements necessary to create comparable indicators that 
address the needs of policy-makers are likely to be: appropriate methods of
summarizing complex information; a narrative that picks out the key issues 
and uncertainties; a diagnosis of why the reported variations are arising; and
the implications for policy action. It is nevertheless important to note that 
the comparisons might inform but should never be the sole criteria for
recommending policy action. National policies, values and priorities should
always be the starting point for policy action. 
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